Víctor Yáñez-Pérez

2PUBLICATIONS
11CO-AUTHORS
Pharmaceutical delivery technologiesCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Jan 21, 2022
A Pharmacokinetic Study of Mix-160 by LC-MS/MS: Oral Bioavailability of a Dosage Form of Citroflavonoids Mixture.

Jesús Alfredo Araujo-León, Rolffy Ortiz-Andrade, Efrén Hernández-Baltazar

|Jun 06, 2020
Pharmacological characterization of the cardiovascular effect of Nibethione: ex vivo, in vivo and in silico studies.

Amanda Sánchez-Recillas, Gabriel Navarrete-Vázquez, Sergio Hidalgo-Figueroa

Pageof 1

Frequent Collaborators

1 joint publications

Amanda Sánchez-Recillas

1 joint publications

Gabriel Navarrete-Vázquez

1 joint publications

Sergio Hidalgo-Figueroa

1 joint publications

Marcos Bonilla-Hernández

1 joint publications

Rolffy Ortiz-Andrade

1 joint publications

Maximiliano Ibarra-Barajas

1 joint publications

Juan Carlos Sánchez-Salgado

1 joint publications

Jesús Alfredo Araujo-León

1 joint publications

Efrén Hernández-Baltazar

1 joint publications

Emanuel Hernández-Núñez

Frequent Collaborators

1 joint publications

Amanda Sánchez-Recillas

1 joint publications

Gabriel Navarrete-Vázquez

1 joint publications

Sergio Hidalgo-Figueroa

1 joint publications

Marcos Bonilla-Hernández

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
06:14

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

8.4K
Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation
08:03

Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation

Published on : Oct 20, 2022

2.1K
See more related videos

Top Related Videos

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
06:14

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

8.4K
Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation
08:03

Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation

Published on : Oct 20, 2022

2.1K
See more related videos